Viviane Monges's most recent trade in Adc Therapeutics SA was a trade of 2,584 Common Shares done at an average price of $3.6 . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Viviane Monges | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.58 per share. | 13 Jun 2025 | 2,584 | 144,043 | - | 3.6 | 9,251 | Common Shares |
| Adc Therapeutics SA | Viviane Monges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 146,627 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Viviane Monges | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 1,437 | 106,627 | - | 2.9 | 4,153 | Common Shares |
| Adc Therapeutics SA | Viviane Monges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 108,064 | - | 0 | Common Shares |